This inventor holds 2 USPTO granted patents. Top assignees: Evotec International Gmbh, Evotech International Gmbh, Exscientia Ltd.. Active years: 2023-2026.
Company Filing History:
1 out of 16 
1 out of 1 
1 out of 1 Years Active: 2023-2026
Title: Stephanie Versluys: Innovator in Pharmaceutical Chemistry
Introduction
Stephanie Versluys is a notable inventor based in Toulouse, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.
Latest Patents
Stephanie holds a patent for "Pyrazolopyrimidine compounds as adenosine receptor antagonists." This invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate, or salt thereof. The compound includes a salt of such an ester, amide, or carbamate, wherein R is an optionally substituted phenyl or an optionally substituted 5- or 6-membered aromatic heterocycle. Additionally, R is an optionally substituted 5- or 6-membered aromatic heterocycle. The patent also covers pharmaceutical compositions comprising a compound of formula (I). She has 1 patent to her name.
Career Highlights
Throughout her career, Stephanie has worked with prominent companies in the pharmaceutical industry, including Exscientia Ltd. and Evotec International GmbH. Her work has focused on innovative solutions in drug development and therapeutic applications.
Collaborations
Stephanie has collaborated with esteemed colleagues such as Andrew Simon Bell and Adrian Michael Schreyer. These partnerships have contributed to her success and advancements in her field.
Conclusion
Stephanie Versluys is a pioneering inventor whose work in pharmaceutical chemistry continues to impact the industry. Her innovative compounds and collaborations highlight her dedication to advancing medical science.